NZ596946A - Solid compositions comprising 5-aminolevulinic acid - Google Patents
Solid compositions comprising 5-aminolevulinic acidInfo
- Publication number
- NZ596946A NZ596946A NZ596946A NZ59694610A NZ596946A NZ 596946 A NZ596946 A NZ 596946A NZ 596946 A NZ596946 A NZ 596946A NZ 59694610 A NZ59694610 A NZ 59694610A NZ 596946 A NZ596946 A NZ 596946A
- Authority
- NZ
- New Zealand
- Prior art keywords
- solid
- hydrogenated
- triglycerides
- active ingredient
- aminolevulinic acid
- Prior art date
Links
- 229960002749 aminolevulinic acid Drugs 0.000 title abstract 4
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008247 solid mixture Substances 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 150000003626 triacylglycerols Chemical class 0.000 abstract 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 abstract 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 abstract 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 abstract 2
- -1 5-ALA ester Chemical class 0.000 abstract 1
- 229920003134 Eudragit® polymer Polymers 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 235000019482 Palm oil Nutrition 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229940110456 cocoa butter Drugs 0.000 abstract 1
- 235000019868 cocoa butter Nutrition 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229940116364 hard fat Drugs 0.000 abstract 1
- 229940049290 hydrogenated coco-glycerides Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 239000002540 palm oil Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003760 tallow Substances 0.000 abstract 1
- 229940113164 trimyristin Drugs 0.000 abstract 1
- 229960001947 tripalmitin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09251538 | 2009-06-11 | ||
| PCT/EP2010/003531 WO2010142456A1 (en) | 2009-06-11 | 2010-06-11 | Solid compositions comprising 5-aminolevulinic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ596946A true NZ596946A (en) | 2014-07-25 |
Family
ID=42628133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ596946A NZ596946A (en) | 2009-06-11 | 2010-06-11 | Solid compositions comprising 5-aminolevulinic acid |
Country Status (18)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2790827A1 (en) | 2010-03-01 | 2011-09-09 | Photocure Asa | Cosmetic compositions |
| DE102012105512A1 (de) * | 2012-06-25 | 2014-04-24 | Hennig Arzneimittel Gmbh & Co. Kg | Arzneiform zur verlängerten Freisetzung von Wirkstoffen |
| US20140067024A1 (en) | 2012-08-30 | 2014-03-06 | Photocure Asa | Dual panel photodynamic therapy lamp |
| GB201221123D0 (en) | 2012-11-23 | 2013-01-09 | Photocure As | Device for photodynamic treatment |
| CN105338962A (zh) * | 2013-03-12 | 2016-02-17 | 应用生物学研究有限公司 | 用于改善的药物递送的螯合栓剂 |
| EP3181125B1 (en) * | 2014-07-31 | 2025-02-19 | Capsugel Belgium NV | Capsule formulation |
| JP6588193B2 (ja) * | 2014-07-31 | 2019-10-09 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ | カプセル製剤 |
| US11623008B2 (en) * | 2014-08-20 | 2023-04-11 | Professional Compounding Centers Of America | Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan |
| US9956426B2 (en) | 2015-02-26 | 2018-05-01 | Amol Punjabi | Upconverting nanoparticles |
| CA3008552C (en) | 2015-12-17 | 2024-01-02 | Photocure Asa | Method of photodynamic therapy (pdt) for bladder cancer |
| GB201522398D0 (en) | 2015-12-18 | 2016-02-03 | Photocure As | Device for photodynamic therapy |
| CN105481946B (zh) * | 2015-12-18 | 2019-05-21 | 浙江工商大学 | 5-氨基酮戊酸与3-羟基吡啶-4-酮的缀合物及其制备法和用途 |
| US10744212B2 (en) | 2016-03-14 | 2020-08-18 | General Electric Company | Topical application of nerve labeling dyes for image-guided surgery |
| GB2546128A (en) * | 2016-09-28 | 2017-07-12 | Photocure Asa | Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same |
| EP3612570A4 (en) | 2017-04-17 | 2021-01-13 | The University of Chicago | POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS |
| CN107434753A (zh) * | 2017-07-26 | 2017-12-05 | 南京大学 | 5‑氨基乙酰丙酸及其衍生物的泡腾片及其制备方法 |
| CA3079496C (en) * | 2017-12-01 | 2021-06-01 | Sbi Pharmaceuticals Co., Ltd. | Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3181062B2 (ja) * | 1991-01-31 | 2001-07-03 | 帝國製薬株式会社 | 下部消化管崩壊経口製剤 |
| CA2215069C (en) * | 1995-03-10 | 2006-09-12 | Photocure As | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| US6492420B2 (en) * | 1995-03-10 | 2002-12-10 | Photocure As | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| EP1104290B1 (en) * | 1998-08-13 | 2010-03-31 | Cima Labs Inc. | Microemulsions as solid dosage forms for oral administration |
| CA2376261A1 (en) * | 1999-06-09 | 2000-12-14 | Mochida Pharmaceutical Co., Ltd. | System for release in lower gastrointestinal tract |
| DE10003620A1 (de) * | 2000-01-28 | 2001-08-02 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln |
| GB0018527D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Composition |
| GB0018528D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Compounds |
| US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| US7264629B2 (en) * | 2001-11-09 | 2007-09-04 | Qlt, Inc. | Photodynamic therapy for the treatment of hair loss |
| TW577606U (en) * | 2001-11-20 | 2004-02-21 | Carry Computer Eng Co Ltd | Improved structure of all-in-one silicon disk |
| DE102005019628A1 (de) * | 2005-04-26 | 2006-11-09 | Technische Universität Braunschweig | Formulierung zur dermalen Anwendung |
| GB0609809D0 (en) * | 2006-05-17 | 2006-06-28 | Photocure Asa | Product |
| GB0724279D0 (en) * | 2007-12-12 | 2008-01-23 | Photocure Asa | Use |
-
2010
- 2010-06-11 SG SG2011090040A patent/SG176687A1/en unknown
- 2010-06-11 CA CA2763837A patent/CA2763837A1/en not_active Abandoned
- 2010-06-11 BR BRPI1011650A patent/BRPI1011650A2/pt not_active IP Right Cessation
- 2010-06-11 US US13/377,692 patent/US20120134921A1/en not_active Abandoned
- 2010-06-11 JP JP2012514392A patent/JP2012529451A/ja not_active Ceased
- 2010-06-11 NZ NZ596946A patent/NZ596946A/en not_active IP Right Cessation
- 2010-06-11 MX MX2011013069A patent/MX2011013069A/es not_active Application Discontinuation
- 2010-06-11 EP EP10725043A patent/EP2440188A1/en not_active Withdrawn
- 2010-06-11 AU AU2010257752A patent/AU2010257752B2/en not_active Expired - Fee Related
- 2010-06-11 CN CN2010800256075A patent/CN102802612A/zh active Pending
- 2010-06-11 KR KR1020117030694A patent/KR20140014401A/ko not_active Withdrawn
- 2010-06-11 PE PE2011002072A patent/PE20120858A1/es not_active Application Discontinuation
- 2010-06-11 WO PCT/EP2010/003531 patent/WO2010142456A1/en not_active Ceased
- 2010-06-11 RU RU2011150920/15A patent/RU2527328C2/ru not_active IP Right Cessation
-
2011
- 2011-12-01 ZA ZA2011/08850A patent/ZA201108850B/en unknown
- 2011-12-05 CR CR20110649A patent/CR20110649A/es unknown
- 2011-12-07 CL CL2011003115A patent/CL2011003115A1/es unknown
- 2011-12-27 CO CO11179486A patent/CO6480960A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010142456A1 (en) | 2010-12-16 |
| JP2012529451A (ja) | 2012-11-22 |
| KR20140014401A (ko) | 2014-02-06 |
| CL2011003115A1 (es) | 2012-06-22 |
| EP2440188A1 (en) | 2012-04-18 |
| PE20120858A1 (es) | 2012-08-01 |
| AU2010257752B2 (en) | 2015-04-09 |
| RU2527328C2 (ru) | 2014-08-27 |
| CA2763837A1 (en) | 2010-12-16 |
| AU2010257752A1 (en) | 2012-01-12 |
| US20120134921A1 (en) | 2012-05-31 |
| RU2011150920A (ru) | 2013-07-20 |
| CR20110649A (es) | 2012-03-22 |
| CO6480960A2 (es) | 2012-07-16 |
| ZA201108850B (en) | 2013-02-27 |
| SG176687A1 (en) | 2012-01-30 |
| CN102802612A (zh) | 2012-11-28 |
| BRPI1011650A2 (pt) | 2016-03-22 |
| MX2011013069A (es) | 2012-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ596946A (en) | Solid compositions comprising 5-aminolevulinic acid | |
| JP2012529451A5 (cg-RX-API-DMAC7.html) | ||
| WO2011060945A3 (en) | Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases | |
| HRP20200065T1 (hr) | Upotreba etilnog estera ikozapentaenske kiseline u liječenju hipertrigliceridemije | |
| WO2009091538A8 (en) | Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia | |
| WO2008027991A3 (en) | USE OF DPA(n-6) OILS IN INFANT FORMULA | |
| WO2012013331A3 (en) | Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases | |
| JP2008540394A5 (cg-RX-API-DMAC7.html) | ||
| WO2011060944A8 (en) | Active pharmaceutical ingredient capsules and polyunsaturated fatty acid esters | |
| EP2213335A3 (en) | Personal care compositions having reduced eye irritation | |
| CA2576196A1 (en) | Novel statin pharmaceutical compositions and related methods of treatment | |
| JP2015520235A5 (cg-RX-API-DMAC7.html) | ||
| WO2010128401A9 (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| GB2459809A (en) | Fatty acid formulations and methods of use thereof | |
| WO2009150023A3 (de) | Verfähren zur herstellung von sphingolipiden durch enzymatische n-acylierung von lysosphingolipiden unter verwendung einer lipase und eines fettsäureglycerinesters | |
| MX2009004339A (es) | Alcoholes de acido graso. | |
| HRP20110086T1 (hr) | Dha esteri i njihova upotreba u tretmanu i prevenciji kardiovaskularnih bolesti | |
| EP2213336A3 (en) | Personal care sunscreen compositions having reduced eye irritation | |
| MX2009012782A (es) | Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados. | |
| RU2013112807A (ru) | Композиция для доставки активных агентов в желудок | |
| JP2010531684A5 (cg-RX-API-DMAC7.html) | ||
| JP2010508261A (ja) | 新規脂質化合物 | |
| WO2006111633A3 (fr) | Utilisation de la lecithine comme medicament dans le traitement du psoriasis | |
| JP5548373B2 (ja) | 浴用剤組成物 | |
| CN105861579A (zh) | 一种含有结构油脂的组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 11 JUN 2017 BY PHILLIPS ORMONDE FITZPATRICK Effective date: 20150109 |
|
| LAPS | Patent lapsed |